alirocumab
sanofi,Regeneron
['odyssey']
interesting post hoc propensity-matched analysis from odyssey in suggests post-mi patients who transiently had ldl-c &lt;15 on pcsk9i and then switched to statin monotherapy may have derived sustained benefit vs. statin monotherapy alone #acc23 
Cardiologist + researcher @MGHHeartHealth, Asst Prof @harvardmed. Preventive cardiology, women's health, pregnancy, health policy. Tweets are my own. He/him.